Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2025-12-25 @ 12:43 AM
NCT ID:
NCT04377867
Eligibility Criteria:
Inclusion Criteria:
* Patients diagnosed with LRBA and CTLA4 deficiencies and eligible for the study
* Patients accept consent to participate in this study and followed prospectively on abatacept treatment.
Exclusion Criteria:
* History of hypersensitivity to abatacept
* History of acquired immunodeficiency diseases like HIV
* EBV viremia during the study screening
* Documented malignancy
* Current active infectious disease (bacterial or fungal) like tuberculosis
* Chronic hepatitis B or hepatitis C infections
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
1 Year
Maximum Age:
60 Years
Study:
NCT04377867
Study Brief:
Protocol Section:
NCT04377867